About Fluofarma
Fluofarma: Revolutionizing Preclinical Drug Development with Porsolt
Fluofarma is a leading Contract Research Organization (CRO) that specializes in preclinical drug development. The company has been providing its services to clients worldwide for many years and has established itself as a trusted partner in the pharmaceutical industry. Fluofarma's parent company, Porsolt, is an internationally recognized Global CRO that offers a wide range of services to assist clients at all stages of the preclinical drug development process.
At Fluofarma, we understand the importance of preclinical research in drug development. Our team of experts works tirelessly to ensure that our clients' projects are completed on time and within budget while maintaining the highest standards of quality. We are committed to providing our clients with personalized service and support throughout their project's lifecycle.
Our state-of-the-art facility is GLP compliant and AAALAC accredited, ensuring that all studies conducted at Fluofarma meet or exceed regulatory requirements. We offer a comprehensive range of preclinical services, including pharmacology studies, toxicology studies, safety pharmacology studies, bioanalytical services, and more.
Pharmacology Studies
Our pharmacology studies evaluate the efficacy of potential drugs by measuring their effects on biological systems. These studies help identify promising compounds for further development while also providing valuable insights into their mechanisms of action.
Toxicology Studies
Toxicology studies assess the safety profile of potential drugs by evaluating their effects on various organs and systems within the body. These studies help identify any potential adverse effects early in the drug development process before they can become significant issues.
Safety Pharmacology Studies
Safety pharmacology studies evaluate how potential drugs affect vital organ systems such as cardiovascular function or respiratory function. These tests help identify any safety concerns related to these critical functions early in drug development.
Bioanalytical Services
Bioanalytical services involve analyzing biological samples such as blood or urine for specific compounds. These services are essential for determining the pharmacokinetics and pharmacodynamics of potential drugs, which can help optimize dosing regimens and improve efficacy.
At Fluofarma, we pride ourselves on our ability to provide customized solutions to meet our clients' unique needs. Our team of experts has extensive experience in preclinical drug development and is committed to delivering high-quality results that exceed expectations.
In conclusion, Fluofarma is a leading CRO that specializes in preclinical drug development. Our parent company, Porsolt, is an internationally recognized Global CRO that offers a wide range of services to assist clients at all stages of the preclinical drug development process. We are committed to providing personalized service and support throughout your project's lifecycle while maintaining the highest standards of quality. Contact us today to learn more about how we can help you revolutionize your preclinical drug development process!